SciHub
文献互助
期刊查询
一搜即达
科研导航
交流社区
登录
注册
发布
文献
求助
首页
我的求助
捐赠本站
已入深夜,您辛苦了!由于当前在线用户较少,发布求助请尽量完整的填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!祝你早点完成任务,早点休息,好梦!
武雨珍
Lv7
3810 积分
2021-08-04 加入
最近求助
最近应助
互助留言
Maintenance Therapy in Acute Myeloid Leukemia
1天前
求助中
Mini-hyper-CVD plus inotuzumab ozogamicin, with or without blinatumomab, in the subgroup of older patients with newly diagnosed Philadelphia chromosome-negative B-cell acute lymphocytic leukaemia: long-term results of an open-label phase 2 trial
1天前
已完结
Advancements and challenges in CAR T cell therapy in autoimmune diseases
2天前
已完结
Management of relapsed/refractory mantle cell lymphoma
4天前
已完结
Feasibility of a Novel Academic BCMA-CART (HBI0101) for the Treatment of Relapsed and Refractory AL Amyloidosis
11天前
已完结
Activity of venetoclax in patients with relapsed or refractory chronic lymphocytic leukaemia: analysis of the VENICE-1 multicentre, open-label, single-arm, phase 3b trial
14天前
已完结
Predictive value of the CLL-IPI in CLL patients receiving chemo-immunotherapy as first-line treatment
18天前
已完结
Future Developments in Light Chain Amyloidosis Management
23天前
已完结
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
23天前
已完结
Anti-LAG-3 boosts CD8 T cell effector function
23天前
已完结
没有进行任何应助
感谢,点赞
1天前
感谢,点赞
2天前
感谢,点赞,速度真快
4天前
感谢,点赞
11天前
感谢,点赞
14天前
感谢,点赞
17天前
感谢,点赞
22天前
感谢,点赞
23天前
点赞,感谢
23天前
点赞,感谢
23天前
最近帖子
最近评论
没有发布任何帖子
没有发布任何评论